Identification of FGFR4 as a potential therapeutic target for advanced-stage, high-grade serous ovarian cancer
about
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancerIndividualized medicine enabled by genomics in Saudi ArabiaPreclinical Activity of ARQ 087, a Novel Inhibitor Targeting FGFR DysregulationIs fibroblast growth factor receptor 4 a suitable target of cancer therapy?The Fibroblast Growth Factor signaling pathwayDevelopment of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors.Inferring active and prognostic ligand-receptor pairs with interactions in survival regression models.Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.WNT7A/β-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer.Genetic variants in the fibroblast growth factor pathway as potential markers of ovarian cancer risk, therapeutic response, and clinical outcomeCellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis.High Expression of FGFR4 Enhances Tumor Growth and Metastasis in Nasopharyngeal CarcinomaElectrochemical sensor for rapid determination of fibroblast growth factor receptor 4 in raw cancer cell lysates.Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer.FGF18 as a prognostic and therapeutic biomarker in ovarian cancer.Fibroblast growth factor receptor 4 induced resistance to radiation therapy in colorectal cancer.Prognostic biomarkers in endometrial and ovarian carcinoma.Harnessing the potential of lipid-based nanomedicines for type-specific ovarian cancer treatments.Ovarian cancer: diagnostic, biological and prognostic aspects.The over-expression of FGFR4 could influence the features of gastric cancer cells and inhibit the efficacy of PD173074 and 5-fluorouracil towards gastric cancer.Silencing of FGFR4 could influence the biological features of gastric cancer cells and its therapeutic value in gastric cancer.Photoactivation approaches reveal a role for Rab11 in FGFR4 recycling and signalling.Deguelin-induced blockade of PI3K/protein kinase B/MAP kinase signaling in zebrafish and breast cancer cell lines is mediated by down-regulation of fibroblast growth factor receptor 4 activity.Polymorphisms of FGFR1 in HBV-related hepatocellular carcinoma.Fibroblast growth factor signaling is required for early somatic gonad development in zebrafish.MicroRNA-327 regulates cardiac hypertrophy and fibrosis induced by pressure overload.How can molecular abnormalities influence our clinical approach.Increased Expression of Holliday Junction-Recognizing Protein (HJURP) as an Independent Prognostic Biomarker in Advanced-Stage Serous Ovarian Carcinoma.Cytotoxic Conjugates of Fibroblast Growth Factor 2 (FGF2) with Monomethyl Auristatin E for Effective Killing of Cells Expressing FGF Receptors.
P2860
Q26780387-339ACB20-4C43-45CE-A55B-8016C5196A39Q26861059-DA047BC6-3669-460D-94D7-52A7B357F47AQ27322795-A93A134B-9BFC-4CE2-9EB1-567990FE2854Q33751398-B5355AA9-8B55-404F-8A03-4AEC7CD07FBEQ34467171-EFABBDA7-E3A3-4F0C-9338-E202464D5C07Q34525925-54304CA8-8DDE-40C2-89D4-F7D54A0D4873Q35026818-333625DB-DBCE-4518-A273-6E59ED34A059Q35069479-8A3010DA-EFBF-41CA-9D44-B1D89D0868A4Q35133487-AC36D5EF-35AF-42FD-BDB7-D83E8D0D5590Q35623040-50C11814-C027-4DE6-82B9-8AAB454FFFE1Q36122605-8C05C325-112D-49ED-8E70-CA1D1055BBBCQ36214131-B4569E8A-1CD7-4887-8838-49F07D5385EAQ36334104-61B6CF36-0E82-4003-8026-6AADBA0F0C19Q36689039-DF0403C2-407F-4073-8491-3BD64A5E058EQ37200903-A2E72B79-D7D1-4C85-8B63-D90314498692Q37688471-4BE88D7D-45A5-4670-821E-20F6D601ABFCQ38185940-4AA1A40C-7588-4EEF-B99A-9F2F9E47E7F2Q38205584-CF725BE8-F764-4096-89B5-B6AAE3C3FD72Q38261795-4A292F01-E460-4BF7-98B0-B0E09A8BEBF7Q38812018-308544D6-A618-45C4-A9E5-0F14A3BE91B4Q38830668-57AD98C8-0F83-42AA-97F9-88143C25CD80Q39019114-A2E348AB-26EF-4956-AC01-4877C6B2D67CQ39382063-CFFF887B-0FB6-4A6E-A7C6-1381E4E4E555Q41166121-C4D20297-9010-40B0-B071-0EEDD1AF0FA4Q41702266-DE3475D9-F7AB-4A99-BD4E-D1FF7FF1515AQ49379816-611EA659-475A-4E71-9BB2-FCBC0EF80F03Q49896005-271729B3-AA61-4914-BA97-F8D3FC80E166Q55195623-22857A8D-6D53-4682-8A97-225357BA8214Q55669491-29981965-8773-4BD6-AD51-CC4F1252F7CA
P2860
Identification of FGFR4 as a potential therapeutic target for advanced-stage, high-grade serous ovarian cancer
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Identification of FGFR4 as a p ...... gh-grade serous ovarian cancer
@ast
Identification of FGFR4 as a p ...... gh-grade serous ovarian cancer
@en
type
label
Identification of FGFR4 as a p ...... gh-grade serous ovarian cancer
@ast
Identification of FGFR4 as a p ...... gh-grade serous ovarian cancer
@en
prefLabel
Identification of FGFR4 as a p ...... gh-grade serous ovarian cancer
@ast
Identification of FGFR4 as a p ...... gh-grade serous ovarian cancer
@en
P2093
P2860
P1476
Identification of FGFR4 as a p ...... gh-grade serous ovarian cancer
@en
P2093
Anil K Sood
Cecilia S Leung
Cristian Rodriguez-Aguay
Gabriel Lopez-Berestein
Kwong-Kwok Wong
Melissa S Thompson
Michael J Birrer
Ngai-Na Co
Rosie S Schmandt
Samuel C Mok
P2860
P304
P356
10.1158/1078-0432.CCR-12-2736
P407
P577
2013-01-23T00:00:00Z